Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data

Abstract

AIMS Hyperphosphatemia has been associated with an increased risk of mortality in patients with end-stage renal disease. We sought to assess the real-world effectiveness of sucroferric oxyhydroxide (SO), an iron-based phosphate binder (PB), in control of serum phosphorus levels, and to determine the associated pill burden in hemodialysis patients… (More)
DOI: 10.5414/CN109021

Topics

7 Figures and Tables

Cite this paper

@inproceedings{Coyne2017RealworldEO, title={Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data }, author={Daniel W. Coyne and Linda H. Ficociello and Vidhya Parameswaran and Ludmila Anderson and Sharanya Vemula and Norma J. Ofsthun and Claudy Mullon and Franklin Maddux and Robert J. Kossmann and Stuart M. Sprague}, booktitle={Clinical nephrology}, year={2017} }